Can Pfizer, Johnson & Johnson Continue Outperforming the Index?

Large-cap pharmaceuticals Pfizer Inc. (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ) are among stocks outperforming the broader market in the past year, particularly in the past three months. Both stocks are S&P 500 components, so a comparison with that index offers an appropriate benchmark for pharmaceutical stocks. – MarketBeat

While the pharma industry has languished, these companies offer examples of company-specific news that can boost prices even amid wider malaise.

Pfizer is up 6.69% in the past month and 9.78% in the past three months. Shares closed Wednesday at $50.24, a gain of $0.53 or 1.07%. That’s compared to the S&P’s return of 3.34%

→ Continue reading at Entrepreneur

More from author

Related posts


Latest posts

Concurrent sales require excellent communication and attention to details 

Q: Last week, we bought a house contingent upon the sale of our condo. For this reason, we listed our condo for sale on...

Five-bedroom home in Danville sells for $2.3 million

107 Fairwood Court – Google Street ViewA spacious house built in 1999 located in the 100 block of Fairwood Court in Danville has new...

Four-bedroom home in San Jose sells for $2.7 million

2132 Cedarwood Lane – Google Street View A 2,776-square-foot house built in 1966 has changed hands. The spacious property located in the 2100 block...